LncRNA HCG18 Promotes Clear Cell Renal Cell Carcinoma Progression by Targeting miR-152-3p to Upregulate RAB14

References

• Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J. Clin. 2011;61:69–90. doi:10.3322/caac.2010721296855
   PubMed Web of Science ®Google Scholar
• Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol. 2003;27:612–624. doi:10.1097/00000478-200305000-0000512717246
   PubMed Web of Science ®Google Scholar
• Motzer RJ, Molina AM. Targeting renal cell carcinoma. J Clin Oncol. 2009;27:3274–3276. doi:10.1200/JCO.2009.21.846119451422
   PubMed Web of Science ®Google Scholar
• Xie L, Li H, Zhang L, et al. Autophagy-related gene P4HB: a novel diagnosis and prognosis marker for kidney renal clear cell carcinoma. Aging. 2020;12:1828–1842. doi:10.18632/aging.10271532003756
   PubMedGoogle Scholar
• Cheng G, Li M, Ma X, et al. Systematic analysis of microRNA biomarkers for diagnosis, prognosis, and therapy in patients with clear cell renal cell carcinoma. Front Oncol. 2020;10:543817. doi:10.3389/fonc.2020.54381733344224
   PubMed Web of Science ®Google Scholar
• Xie L, Dang Y, Guo J, et al. High KRT8 expression independently predicts poor prognosis for lung adenocarcinoma patients. Genes. 2019;10.
   PubMed Web of Science ®Google Scholar
• Wilusz JE, Sunwoo H, Spector DL. Long noncoding RNAs: functional surprises from the RNA world. Genes Dev. 2009;23:1494–1504. doi:10.1101/gad.180090919571179
   PubMed Web of Science ®Google Scholar
• Lv D, Xiang Y, Yang Q, Yao J, Dong Q. Long Non-Coding RNA TUG1 promotes cell proliferation and inhibits cell apoptosis, autophagy in clear cell renal cell carcinoma via MiR-31-5p/FLOT1 axis. Onco Targets Ther. 2020;13:5857–5868. doi:10.2147/OTT.S25463432606796
   PubMed Web of Science ®Google Scholar
• Jiao M, Guo H, Chen Y, Li L, Zhang L. DARS-AS1 promotes clear cell renal cell carcinoma by sequestering miR-194-5p to up-regulate DARS. Biomed. Pharmacother. 2020;128:110323. doi:10.1016/j.biopha.2020.11032332526457
   PubMed Web of Science ®Google Scholar
• Ma F, An K, Li Y. Silencing of long non-coding RNA-HCG18 Inhibits the tumorigenesis of gastric cancer through blocking PI3K/Akt pathway. Onco Targets Ther. 2020;13:2225–2234. doi:10.2147/OTT.S24096532256081
   PubMed Web of Science ®Google Scholar
• Xu Z, Huang B, Zhang Q, He X, Wei H, Zhang D. NOTCH1 regulates the proliferation and migration of bladder cancer cells by cooperating with long non-coding RNA HCG18 and microRNA-34c-5p. J Cell Biochem. 2019;120:6596–6604. doi:10.1002/jcb.2795430426533
   PubMed Web of Science ®Google Scholar
• Li L, Ma TT, Ma YH, Jiang YF. LncRNA HCG18 contributes to nasopharyngeal carcinoma development by modulating miR-140/CCND1 and Hedgehog signaling pathway. Eur. Rev. Med. Pharmacol. Sci. 2019;23:10387–10399. doi:10.26355/eurrev_201912_1967831841193
   PubMed Web of Science ®Google Scholar
• Kloosterman WP, Plasterk RH. The diverse functions of microRNAs in animal development and disease. Dev Cell. 2006;11:441–450. doi:10.1016/j.devcel.2006.09.00917011485
   PubMed Web of Science ®Google Scholar
• He C, Yang J, Ding J, et al. MiR-448 targets BLC2 and inhibits the growth of pituitary adenoma cells. Biochem Cell Biol. 2020;1–7.
   Google Scholar
• Wang X, Xiao H, Wu D, Zhang D, Zhang Z. miR-335-5p regulates cell cycle and metastasis in lung adenocarcinoma by targeting CCNB2. Onco Targets Ther. 2020;13:6255–6263. doi:10.2147/OTT.S24513632636645
   PubMed Web of Science ®Google Scholar
• Feng F, Liu H, Chen A, et al. miR-148-3p and miR-152-3p synergistically regulate prostate cancer progression via repressing KLF4. J Cell Biochem. 2019;120:17228–17239. doi:10.1002/jcb.2898431104329
   PubMed Web of Science ®Google Scholar
• Sun J, Tian X, Zhang J, et al. Regulation of human glioma cell apoptosis and invasion by miR-152-3p through targeting DNMT1 and regulating NF2: miR-152-3p regulate glioma cell apoptosis and invasion. J Exp Clin Cancer Res. 2017;36:100. doi:10.1186/s13046-017-0567-428764788
   PubMed Web of Science ®Google Scholar
• Ye Z, Duan J, Wang L, Ji Y, Qiao B. LncRNA-LET inhibits cell growth of clear cell renal cell carcinoma by regulating miR-373-3p. Cancer Cell Int. 2019;19:311. doi:10.1186/s12935-019-1008-631768131
   PubMed Web of Science ®Google Scholar
• Zheng Z, Zhao F, Zhu D, et al. Long non-coding RNA LUCAT1 promotes proliferation and invasion in clear cell renal cell carcinoma through AKT/GSK-3beta signaling pathway. Cell Physiol Biochem. 2018;48:891–904. doi:10.1159/00049195730032137
   PubMedGoogle Scholar
• He GZ, Yu SY, Zhou QP, et al. LncRNA DLEU1 accelerates the malignant progression of clear cell renal cell carcinoma via regulating miRNA-194-5p. Eur. Rev. Med. Pharmacol. Sci. 2019;23:10691–10698. doi:10.26355/eurrev_201912_1976831858537
   PubMed Web of Science ®Google Scholar
• Li S, Wu T, Zhang D, Sun X, Zhang X. The long non-coding RNA HCG18 promotes the growth and invasion of colorectal cancer cells through sponging miR-1271 and upregulating MTDH/Wnt/beta-catenin. Clin Exp Pharmacol Physiol. 2020;47:703–712. doi:10.1111/1440-1681.1323031854468
   PubMed Web of Science ®Google Scholar
• Li W, Pan T, Jiang W, Zhao H. HCG18/miR-34a-5p/HMMR axis accelerates the progression of lung adenocarcinoma. Biomed. Pharmacother. 2020;129:110217. doi:10.1016/j.biopha.2020.11021732559619
   PubMed Web of Science ®Google Scholar
• Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146:353–358. doi:10.1016/j.cell.2011.07.01421802130
   PubMed Web of Science ®Google Scholar
• Abdollahzadeh R, Daraei A, Mansoori Y, Sepahvand M, Amoli MM, Tavakkoly-Bazzaz J. Competing endogenous RNA (ceRNA) cross talk and language in ceRNA regulatory networks: a new look at hallmarks of breast cancer. J Cell Physiol. 2019;234:10080–10100. doi:10.1002/jcp.2794130537129
   PubMed Web of Science ®Google Scholar
• Ge S, Wang D, Kong Q, Gao W, Sun J. Function of miR-152 as a tumor suppressor in human breast cancer by targeting PIK3CA. Oncol Res. 2017;25:1363–1371. doi:10.3727/096504017X1487853697355728247844
   PubMed Web of Science ®Google Scholar
• Yin T, Liu MM, Jin RT, Kong J, Wang SH, Sun WB. miR-152-3p Modulates hepatic carcinogenesis by targeting cyclin-dependent kinase 8. Pathol Res Pract. 2019;215:152406. doi:10.1016/j.prp.2019.03.03430967300
   PubMed Web of Science ®Google Scholar
• Shi J, Zhang Y, Qin B, Wang Y, Zhu X. Long non-coding RNA LINC00174 promotes glycolysis and tumor progression by regulating miR-152-3p/SLC2A1 axis in glioma. J Exp Clin Cancer Res. 2019;38:395. doi:10.1186/s13046-019-1390-x31492194
   PubMed Web of Science ®Google Scholar
• Bernardo BC, Ooi JY, Lin RC, McMullen JR. miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heart. Future Med. Chem. 2015;7:1771–1792. doi:10.4155/fmc.15.10726399457
   PubMed Web of Science ®Google Scholar
• Guo B, Wang W, Zhao Z, et al. Rab14 act as oncogene and induce proliferation of gastric cancer cells via AKT signaling pathway. PLoS One. 2017;12:e0170620. doi:10.1371/journal.pone.017062028107526
   PubMed Web of Science ®Google Scholar
• Yang J, Liang B, Hou S. TMPO-AS1 promotes cervical cancer progression by upregulating RAB14 via sponging miR-577. J. Gene Med. 2019;21:e3125. doi:10.1002/jgm.312531483914
   PubMed Web of Science ®Google Scholar
• Li M, Bian Z, Jin G, et al. LncRNA-SNHG15 enhances cell proliferation in colorectal cancer by inhibiting miR-338-3p. Cancer Med. 2019;8:2404–2413. doi:10.1002/cam4.210530945457
   PubMed Web of Science ®Google Scholar